Bill > SB1581

This bill, known as the "Veterans Mental Health Innovation Act," aims to explore the use of ibogaine, a substance derived from the iboga plant and its related compounds, as a treatment for various conditions, particularly opioid use disorder, co-occurring substance use disorder, and other neurological or mental health issues. The Department of Health and Senior Services is authorized to award grants to in-state entities that meet specific criteria, including a history of research in neurological diseases and substance dependence, a neurosurgery program with advanced clinical and research facilities capable of providing cardiac intensive care, and a commitment to secure matching funds from non-state sources. These entities must also partner with a consortium from another state that has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) and requested breakthrough therapy designation for ibogaine. The bill establishes two dedicated funds: the "Ibogaine Study Fund" for awarding grants and the "Ibogaine Intellectual Property Fund" to receive revenue from any intellectual property or commercial rights arising from the trials, which will then be used for programs assisting veterans or other at-risk populations. Grant recipients are required to submit regular progress and financial reports, and the Department will report annually to the General Assembly. Importantly, the bill specifies that ibogaine can only be prescribed by a physician licensed in the state and administered under their supervision at a hospital or licensed healthcare facility, and these provisions only apply if ibogaine is approved by the FDA for medical use. The bill also includes a provision allowing state agencies to delay implementation if federal waivers or authorizations are necessary.

Military Affairs and Security

https://www.senate.mo.gov/26info/BTS_Web/Bill.aspx?SessionType=R&BillID=1584516